Efficacy of rituximab in dermatomyositis and polymyositis refractory to conventional therapy;Eficacia de rituximab en dermatomiositis y polimiositis refractarias al tratamiento convencional

Reumatologia Clinica

Volumn 9, Issue 2, 2013, Pages 117-119

  Sánchez Fernández, Simón Ángel ^a   Carrasco Fernández, José Antonio ^a   Rojas Vargas, Luisa Marena ^a  

^a HOSPITAL GENERAL LA MANCHA CENTRO   (Spain)

Author keywords

Dermatomyositis; Polymyositis; Refractory; Rituximab

Indexed keywords

RITUXIMAB; STEROID;

ARTICLE; CASE REPORT; DERMATOMYOSITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; POLYMYOSITIS; REMISSION; TREATMENT FAILURE;

ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; DERMATOMYOSITIS; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MIDDLE AGED; POLYMYOSITIS;

EID: 84875373245     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/j.reuma.2012.02.007     Document Type: Article

References (11)

1. Marie I. Therapy of polymyositis and dermatomyositis. Presse Med 2011, 40:e257-e270.
2. López M.C., Palmou N., Pinto J.A. Miositis resistente. Semin Fund Esp Reumatol 2008, 9:144-155.
3. López F.J. Miopatías inflamatorias. Nuevos conceptos. Reumatol Clin 2008, 4(Suppl. 1):S40-S44.
4. Selva A., Trallero E. Miopatías inflamatorias. Dermatomiositis, polimiositis y miositis con cuerpos de inclusión. Reumatol Clin 2008, 4:197-206.
5. Catoggio L.J., Soriano E.R., Rosa J.E. Tratamiento y pronóstico. Reumatol Clin 2009, 5:35-39.
6. Mok C.C., Ho L.Y., To C.H. Rituximab for refractory polymyositis: an open-label prospective study. J Rheumatol 2007, 34:1864-1868.
7. Cooper M.A., Willingham D.L., Brown D.E., French A.R., Shih F.F., White A.J. Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients. Arthritis Rheum 2007, 56:3107-3111.
8. Levine T.D. Rituximab in the treatment of dermatomyositis: an open-label pilot study. Arthritis Rheum 2005, 52:601-607.
9. Chung L., Genovese M.C., Fiorentino D.F. A pilot trial of rituximab in the treatment of patients with dermatomyositis. Arch Dermatol 2007, 143:763-767.
10. García F.J., Chinchilla E., Castillo M.J., González C., Ocaña C., Sánchez J. Evaluación de la eficacia del tratamiento con rituximab asociado a ciclofosfamida en pacientes con miopatía inflamatoria idiopática refractaria. Med Clin (Barc) 2010, 135:256-259.
11. Couderc M., Gottenberg J.E., Mariette X., Hachulla E., Sibilia J., Fain O., et al. Efficacy and safety of rituximab in the treatment of refractory inflammatory myopathies in adults: results from the AIR registry. Rheumatology 2011, 50:2283-2289.